Browsing by Author "Menéndez Menéndez, Javier Abel"

Browsing by Author "Menéndez Menéndez, Javier Abel"

scopusId Menéndez Menéndez, Javier Abel

Now showing items 1-24 of 25

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)

2007 Article

Ferrer Soler, Laura Vázquez Martín, Alejandro Brunet i Vidal, Joan Menéndez Menéndez, Javier Abel et al.

Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling

2008 Article

Oliveras Ferrarós, Cristina Vázquez Martín, Alejandro Colomer, Ramon Llorens Duran, Rafael de et al.

Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models

2011 Article

Oliveras Ferrarós, Cristina Vázquez Martín, Alejandro Queralt, Bernardo Adrados, Manuel et al.

Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment

2012 Article

Oliveras Ferrarós, Cristina Massaguer i Vall-llovera, Anna Vázquez Martín, Alejandro Carrion Salip, Dolors et al.

Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands

2012 Article

Carrion Salip, Dolors Panosa Roqueta, Clara Menéndez Menéndez, Javier Abel Puig i Miquel, Teresa et al.

Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts

2012-04 Article

Cufí González, Sílvia Corominas Faja, Bruna Vázquez Martín, Alejandro Oliveras Ferrarós, Cristina et al.

Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

2013-06-21 Thesis

Oliveras Ferrarós, Cristina

Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment

2014 Article

Menéndez Menéndez, Javier Abel Quirantes Piné, Rosa Rodríguez Gallego, Esther Cufí González, Sílvia et al.

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells

2014 Article

Corominas Faja, Bruna Cuyàs, Elisabet Gumuzio, Juan Bosch Barrera, Joaquim et al.

Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells

2015 Article

González-Bártulos, Marta Aceves Luquero, Clara Qualai, Jamal Cussó Forest, Olaf et al.

Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties

2015-05-13 Article

Cuyàs, Elisabet Martin Castillo, Begoña Corominas Faja, Bruna Massaguer i Vall-llovera, Anna et al.

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype

2015-05-20 Article

Cuyàs, Elisabet Fernández Arroyo, Salvador Corominas Faja, Bruna Rodríguez Gallego, Esther et al.

Bioenergetics mechanism and autophagy in breast cancer stem cells

2015-05-22 Thesis

Cufí González, Sílvia

Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin

2016-03-03 Article

Bosch Barrera, Joaquim Sais, Elia Cañete Abajo, Noemí Marruecos, Jordi et al.

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer

2016-09-12 Article

Queralt, Bernardo Cuyàs, Elisabet Bosch Barrera, Joaquim Massaguer i Vall-llovera, Anna et al.

BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells

2017 Article

Cuyàs, Elisabet Corominas Faja, Bruna Muñoz San Martín, María Martin Castillo, Begoña et al.

The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism

2019-02-27 Article

Guiducci, Giulia Paone, Alessio Tramonti, Angela Giardina, Giorgio et al.

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

2019-03-28 Article

Cuyàs, Elisabet Buxó Pujolràs, Maria Ferri Iglesias, María José Verdura, Sara et al.

Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers

2019-03-31 Article

Pérez Sánchez, Almudena Cuyàs, Elisabet Ruiz Torres, Verónica Agulló Chazarra, Luz et al.

Stratification of cancer and diabetes based on circulating levels of formate and glucose

2019-04-24 Article

Pietzke, Matthias Fernandez Arroyo, Salvador Sumpton, David Mackay, Gillian M. et al.

A multiscale model of epigenetic heterogeneity-driven cell fate decision-making

2019-04-30 Article

Folguera Blasco, Núria Pérez Carrasco, Rubén Cuyàs, Elisabet Menéndez Menéndez, Javier Abel et al.

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

2019-06-25 Article

Verdura, Sara Cuyàs, Elisabet Martin Castillo, Begoña Menéndez Menéndez, Javier Abel

Extra virgin olive oil contains a phenolic inhibitor of the histone demethylase LSD1/KDM1A

2019-07-19 Article

Cuyàs, Elisabet Gumuzio, Juan Lozano Sánchez, Jesús Carreras, David et al.

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

2019-12-11 Article

López Bonet, Eugeni Buxó Pujolràs, Maria Cuyàs, Elisabet Pernas, Sonia et al.

Now showing items 1-24 of 25